A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.

NCT07669727 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

DEVICE: TheraSphere

Sponsor

Boston Scientific Corporation